Marketresearch.biz reports that the Somatostatin Analogs Market size is expected to be worth around USD 11.4 Billion by 2033, ...

Market OverviewThe Global Medical Panel PC Market is projected to experience steady growth over the next decade, expanding from USD 292 Million in 2023 to an estimated USD 396 Million by 2033. This ...

The approval includes multiple strengths of Lanreotide injection, a therapeutic equivalent generic version of Somatuline Depot Injection.

Foreign institutional investors (FIIs) net sold ₹1,874.54 crore worth of shares, while domestic institutional investors (DIIs ...

Cipla Limited on Wen announced that it has received the final approval for its Abbreviated New Drug Application (ANDA) for ...

Cipla, a major pharmaceutical company, has obtained approval from the US Food and Drug Administration (FDA) to market its ...

Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions ...

Drugmaker Cipla on Wednesday announced that the US Food and Drug Administration (USFDA) has granted it final approval for the L ...

Stock Market LIVE Updates | Indian benchmark indices Nifty 50 and Sensex ended the previous trade session mixed. Nifty 50 ended at 22,529.05, while Sensex closed at 73,953.31. Stocks such as BHEL, JK ...

The drugmaker said its product is indicated for the treatment of patients with acromegaly and gastroenteropancreatic ...

Mumbai-headquartered pharma major Cipla US arm has secured final approval from the United States Food and Drug Administration USFDA for its Lanreotide Inje ...

Drug major Cipla on Wednesday said it has received approval from the US health regulator to market a generic medication used ...